Loading...
•
Mar 31, 2024
American Oncology Network Q2 2024 Earnings Report
Reported strong revenue growth driven by patient encounter growth and strategic acquisitions
Key Takeaways
American Oncology Network, Inc. reported a 20.0% increase in revenue to $364.3 million for the first quarter of 2024, driven by a 7.1% growth in patient encounters and strategic acquisitions. The company's net loss before non-controlling interest was $24.9 million, and Adjusted EBITDA was $2.0 million.
Revenue increased by 20.0% to $364.3 million compared to the prior year quarter.
Patient encounters grew by 7.1% compared to the prior year quarter.
17 new providers were added to the AON platform, expanding in Texas and Maryland markets.
Net cash provided by operating activities was $45.1 million, driven by the deferral of $48.3 million of drug payments due to the Change Healthcare issue.
Revenue by Segment
Forward Guidance
AONC did not provide specific forward guidance in this earnings report. The report focuses on Q1 2024 results and strategic initiatives.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...